- Zoetis (NYSE:ZTS +4.2%) Q3 results: Revenues: $1,214M (+0.3%); COGS: $421M (-3.0%); R&D Expense: $91M (-2.2%); SG&A: $374M (-5.1%); Net Income: $189M (+13.9%); EPS: $0.38 (+15.2%); Quick Assets: $635M (+5.8%).
- 2015 Guidance: Revenue: $4,700M - 4,775M; Adjusted SG&A Expenses: $1,375M - 1,405M; Adjusted R&D Expenses: $350M - 370M; Adjusted interest expense and other (income)/deductions: ~110M; Adjusted diluted EPS: $1.70 - 1.74; Adjusted net income: $855M - 875M; Reported diluted EPS: $0.82 - 0.89; Reported net income: ~$415M - 450M.
- 2016 Guidance: Revenue: $4,750M - 4,875M; Adjusted SG&A Expenses: $1,310M - 1,360M; Adjusted R&D Expenses: $360M - 380M; Adjusted EPS: $1.84 - 1.94; Adjusted net income: $925M - 975M; Reported EPS: $1.50 - 1.68; Reported net income: ~$755M - 845M.
- 2017 Guidance: Revenue: $5,025M - 5,225M; Adjusted SG&A Expenses: $1,270M - 1,360M; Adjusted R&D Expenses: $360M - 380M; Adjusted EPS: $2.24 - 2.38; Adjusted net income: $1,125M - 1,195M; Reported EPS: $2.04 - 2.22; Reported net income: ~$1,025M - 1,115M.